Get tested for CBS gene mutation here.
What is the CBS Gene?
The CBS gene, also known as the cystathionine beta-synthase gene, is a crucial component of our genetic makeup. The CBS protein plays a significant role in various diseases, including homocystinuria and cancer. It provides the instructions for producing the enzyme cystathionine beta-synthase, which plays a vital role in the transsulfuration pathway. This pathway is essential for converting the amino acid homocysteine into cystathionine, a precursor to cysteine. Located on chromosome 21q22.3, the CBS gene consists of 23 exons that encode a 551 amino acid protein. This gene’s proper function is critical for maintaining the balance of amino acids in the body and ensuring the smooth operation of various metabolic processes. Mutations in this gene can lead to cystathionine beta synthase deficiency, which is associated with hyperhomocysteinemia and has significant implications for cardiovascular health.
CBS Gene Function and Health Risks
The primary function of the CBS gene is to produce the enzyme cystathionine beta-synthase, which is essential for metabolizing homocysteine. CBS mutations can have significant implications for health, particularly in the context of high copper levels and potential health problems stemming from CBS upregulation. Elevated levels of homocysteine in the blood are a known risk factor for cardiovascular diseases, including coronary artery disease, stroke, and peripheral artery disease. By converting homocysteine into cystathionine, the CBS gene helps to regulate homocysteine levels and reduce the risk of these conditions. Additionally, the CBS gene plays a role in the production of other amino acids, such as cysteine, which are important for protein synthesis and the maintenance of healthy skin, hair, and nails. Therefore, any mutations in the CBS gene can have significant implications for cardiovascular health and overall well-being. When mutations occur, potentially toxic compounds build up, leading to serious health issues.
Types of Cystathionine Beta Synthase Mutations
Several types of cystathionine beta synthase mutations can impact the function of the cystathionine beta-synthase enzyme, each with its own set of health implications:
C699T: This mutation is associated with increased CBS activity, leading to an accumulation of ammonia in the body. Elevated ammonia levels can cause various health issues, including neurological symptoms.
C1080T: Individuals with this mutation may have a mild risk of developing non-Hodgkin lymphoma and an increased risk of cancer, particularly when dietary intake of vitamin B6 and methionine is low.
G1330A: This mutation results in reduced CBS activity, causing an accumulation of homocysteine in the body. High homocysteine levels are linked to an increased risk of cardiovascular diseases.
T833C: This mutation is associated with elevated homocysteine levels in the blood, which can heighten the risk of cardiovascular diseases.
Understanding these mutations can help in managing and mitigating the associated health risks through targeted interventions and lifestyle adjustments.
What are cystathionine beta synthase gene mutations?
Cystathionine beta synthase (CBS) catalyzes the first step of the transsulfuration pathway, from homocysteine to cystathionine. CBS overexpressing cells enhance the flux through the transsulfuration pathway, aiding in mitigating ferroptosis induced by cystine deprivation. CBS defects are actually an upregulation of the CBS enzyme. This means the enzyme works too fast. In these patients, it’s common to see low levels of cystathionine and homocysteine since there is a rapid conversion to taurine. This leads to high levels of taurine and ammonia. The CBS enzyme is crucial for the production of the amino acid cysteine through the transsulfuration pathway. Specific mutations, like the substitution of threonine for the amino acid isoleucine at position 278 in the cystathionine beta-synthase enzyme, disrupt its normal function. This common mutation involving the amino acid threonine affects the enzyme’s function and leads to elevated homocysteine levels, contributing to associated health issues. The CBS upregulation has been clinically observed to result in sulfur intolerance in some patients. It has also been observed that BH4 can also become depleted with a CBS upregulation.
BH4 helps regulate neurotransmitters and mood. Other mutations, such as MTHFR A1298C, chronic bacterial infections, and aluminum can also lead to low BH4 levels. Lack of BH4 can lead to mast cell degranulation and possibly mast cell activation disorder (MCAD).
CBS problems / Symptoms
Possible high (excess) copper:
Nervous system – anxiety, agitation, depression, aggression
Neurological disorders – impaired mental function, dyslexia, learning disabilities, emotional disturbances
Blood – iron deficiency anemia
Liver impairment – Wilson’s disease
Immune system – prolonged viral infections, fungal infections, poor wound healing
Reproductive Hormonal imbalances – Premenstrual Syndrome (PMS)
Adrenal Gland – Adrenal insufficiency and weakness
Gastrointestinal – constipation, gastritis
Cardiovascular – hypercholesterolemia
Cardiovascular disease – CBS gene mutations can increase homocysteine levels, which are linked to a higher risk of developing cardiovascular disease. Cystathionine beta synthase deficiency, a genetic mutation related to homocysteine metabolism, is associated with hyperhomocysteinemia and various health outcomes, including cardiovascular diseases. Additionally, CBS plays a crucial role in the central nervous system by producing hydrogen sulfide (H2S), which is important for cognitive and vascular functions, and its dysfunction is implicated in various CNS-related disorders.
Gallbladder – abnormal function, gallstone formation
Musculoskeletal – scoliosis, poor collagen and elastin production, osteoarthritis
Others:
Possible low zinc (Poor sense of taste or smell, white marks on more than two fingernails, frquent infections, stretch marks, acne or greasy skin, low fertility, pale skin, tendency to depression, loss of appetite)
Possible pyrroles
Oxidative stress – low cysteine therefore low glutathione
Gut problems that may increase ammonia
Increased hydrogen sulfide will usually present as dizziness/low blood pressure
High homocysteine – Low H2S will usually mean high blood pressure, low cysteine/low B6
Inability to tolerate onion, garlic, eggs, cabbage (ie: high sulphur foods, Preservative 220 (sulphur dioxide) in wine & foods
BH4 deficiency (Depression, anxiety, mood problems, panic attacks)
Molybdenum deficiencies (Excess copper or sulphate interferes with its utilization, breathing difficulty, neurological disorders
Vitamin B1, deficiencies (Tender muscles, eye pains, panic attacks, irritability, poor concentration, prickly legs, poor memory, stomach pains, constipation, tingling hands, and rapid heartbeat)
B2 deficiencies (Burning or gritty eyes, sensitivity to bright lights, sore tongue, cataracts, dull or oily hair, eczema, dermatitis, split nails, cracked lips)
Vitamin B6 deficiencies (Infrequent dream recall, water retention, tingling hands, depression, nervousness, irritability, muscle tremors or cramps, lack of energy, flaky skin)
Note: While some physicians think the CBS mutation is one of the most important mutations to address, there is very little medical research to support these claims and some doctors in the field disagree. In normal populations, studies have shown CBS upregulations to be protective against high homocysteine. However, CBS upregulations have shown to be harmful in Down Syndrome. Medical research has not determined if CBS upregulations are harmful in those with syndromes or disorders leading to impaired methylation.
CBS Gene Expression, Methylation & Methionine / Homocysteine Pathways
CBS A13637G
A360A
CBS C*351T
CBS C1915OT
Test C699T
CBS G*299A
Test CBS T*330C
Genetic factors play a significant role in influencing plasma levels of homocysteine (Hcy) and are associated with hyperhomocysteinemia (HHC). Further research is needed to understand how genetic variations contribute to the prevalence of HHC and its implications for vascular disease.
CBS Transsulfuration Pathway and Hydrogen Sulfide
CBS A13637G A360A CBS C351T CBS C19150T (Test) CBS C699T CBS G299A CBS T*330C
Cystathionine β synthase (CBS) is a crucial enzyme in the transsulfuration pathway that converts homocysteine to cystathionine, a precursor for cysteine synthesis. The essential amino acid methionine is converted to homocysteine by the CBS enzyme, and mutations in the CBS gene can disrupt this process, leading to conditions like homocystinuria and the accumulation of homocysteine, which can cause various health issues. Genetic polymorphisms of CBS may contribute to conditions such as hyperhomocysteinemia and have implications for cardiovascular diseases and metabolic disorders.
Looking for CBS gene mutation treatments, contact us here
CBS Activity and Cancer
Role of CBS in Cancer Cells
The CBS gene plays a pivotal role in the metabolism of sulfur-containing amino acids, which are crucial for the growth and proliferation of cancer cells. Elevated CBS expression has been observed in various types of cancer, including ovarian, breast, and lung cancers. This overexpression is not just a marker but an active participant in cancer progression.
One of the key functions of CBS in cancer cells is the production of hydrogen sulfide (H2S), a gasotransmitter that has been implicated in promoting cancer cell growth, migration, and invasion. H2S achieves this by activating various signaling pathways that are essential for cancer cell survival and proliferation. Consequently, high levels of CBS expression are often associated with poor prognosis and reduced survival rates in cancer patients.
Research has shown that inhibiting CBS can suppress cancer cell growth and induce apoptosis, or programmed cell death, in various cancer cell lines. This makes the CBS gene a potential therapeutic target for cancer treatment. Scientists are exploring CBS inhibitors as a novel approach to cancer therapy, aiming to disrupt the metabolic pathways that cancer cells rely on for growth and survival.
CBS Inhibitor and Therapeutic Strategies
Potential Therapeutic Applications
CBS inhibitors have emerged as promising therapeutic agents in the fight against cancer. These inhibitors work by reducing the production of hydrogen sulfide (H2S), thereby suppressing cancer cell growth and inducing apoptosis. This mechanism has shown potential in treating various cancers, including ovarian, breast, and lung cancers.
Moreover, CBS inhibitors can enhance the effectiveness of traditional cancer treatments such as chemotherapy and radiation therapy. By increasing the sensitivity of cancer cells to these treatments, CBS inhibitors can potentially improve treatment outcomes and reduce the required doses of chemotherapy and radiation, thereby minimizing side effects.
Beyond cancer, CBS inhibitors may also have therapeutic applications in other diseases. For instance, they could be beneficial in treating neurodegenerative disorders and cardiovascular diseases, where abnormal CBS activity and H2S production play a role. However, further research is needed to fully explore the therapeutic potential of CBS inhibitors and to identify the most effective compounds for clinical use.
Testing and Diagnosis
How to Identify CBS Gene Mutations
Identifying CBS gene mutations is a crucial step in understanding and managing the associated health risks. Genetic testing is the primary method used to detect these mutations. This testing can be performed using a blood sample or a cheek swab, making it a relatively simple and non-invasive process. The tests can identify specific mutations in the CBS gene, such as C699T, C1080T, and G1330A, which are linked to various health issues. By pinpointing these mutations, individuals can better understand their risk of developing CBS-related disorders and take proactive steps to manage their health.
Available Testing Methods
Several advanced testing methods are available to identify CBS gene mutations, each with its own advantages:
PCR (Polymerase Chain Reaction): This method amplifies specific regions of the CBS gene, making it easier to detect mutations. It’s a widely used technique due to its accuracy and efficiency.
DNA Sequencing: This method determines the exact sequence of nucleotides in the CBS gene, allowing for precise identification of mutations. It’s particularly useful for detecting rare or complex mutations.
Genotyping: This method analyzes specific genetic markers within the CBS gene to identify mutations. It’s a cost-effective option for screening known variants.
Next-Generation Sequencing (NGS): This comprehensive method sequences the entire CBS gene, providing a detailed view of all potential mutations. It’s ideal for thorough genetic analysis.
Genetic Panels: These panels test for multiple genetic mutations, including those in the CBS gene, offering a broad overview of potential genetic disorders. They are useful for individuals with a family history of genetic conditions.
By utilizing these testing methods, healthcare providers can accurately identify CBS gene mutations and develop personalized management plans for affected individuals.
Managing CBS Gene Mutations
Strategies for Effective Management
Effectively managing CBS gene mutations involves a multifaceted approach that includes lifestyle modifications, dietary changes, and nutritional supplements. Here are some key strategies:
Dietary Modifications: Adopting a diet rich in fruits, vegetables, and whole grains can help reduce homocysteine levels. These foods provide essential nutrients that support overall health and metabolic function.
Folic Acid** Supplementation**: Folic acid is vital for the proper function of the cystathionine beta-synthase enzyme. Supplementing with folic acid can help regulate homocysteine levels and support cardiovascular health.
Vitamin B6 Supplementation: As a co-factor for the CBS enzyme, vitamin B6 is crucial for its activity. Ensuring adequate intake through diet or supplements can aid in maintaining enzyme function and reducing homocysteine levels.
Amino Acid Supplementation: Supplementing with specific amino acids, such as cysteine, can support the CBS enzyme’s function and help maintain a healthy balance of amino acids in the body.
Avoiding Potentially Toxic Compounds: Individuals with CBS gene mutations should avoid sulfur-containing amino acids and other potentially toxic compounds that can exacerbate homocysteine buildup.
Regular Exercise: Engaging in regular physical activity can help lower homocysteine levels and improve overall cardiovascular health. Exercise also supports metabolic processes and enhances well-being.
Stress Management: Stress can worsen the symptoms of CBS gene mutations. Incorporating stress management techniques, such as meditation, yoga, and deep breathing exercises, can help mitigate these effects.
Genetic Counseling: Consulting with a genetic counselor can provide valuable insights into the risks associated with CBS gene mutations. Genetic counseling can help individuals make informed decisions about their health and develop personalized management plans.
Additionally, the administration of the CBS inhibitor AOAA affects visceral hypersensitivity in a dose dependent manner, with significant effects on abdominal visceromotor responses and distension thresholds observed according to the dosage administered.
By following these strategies, individuals with CBS gene mutations can effectively manage their condition, reduce their risk of developing related disorders, and improve their overall quality of life.
Nutritional Considerations
For individuals with CBS gene mutations, dietary adjustments can play a crucial role in managing their condition. Here are some key nutritional considerations:
Folic Acid Supplementation: Folic acid acts as a co-factor for the cystathionine beta-synthase enzyme. Supplementing with folic acid can support the enzyme’s function and help regulate homocysteine levels.
Vitamin B6 Supplementation: Like folic acid, vitamin B6 is a co-factor for the CBS enzyme. Ensuring adequate intake of vitamin B6 through diet or supplements can aid in maintaining enzyme activity.
Methionine Restriction: Reducing the intake of methionine-rich foods, such as meat and fish, can help manage the condition by preventing excessive accumulation of homocysteine.
Amino Acid Supplementation: Supplementing with specific amino acids, such as cysteine, can support the function of the CBS enzyme and help maintain a healthy balance of amino acids in the body.
These nutritional strategies can be tailored to individual needs, helping to optimize health and manage the effects of CBS gene mutations.
Lifestyle Considerations
Managing CBS gene mutations often requires making certain lifestyle adjustments. Here are some important considerations:
Avoiding High-Sulfur Foods: Foods high in sulfur, such as garlic and onions, can exacerbate symptoms associated with CBS gene mutations. Limiting these foods can help manage the condition.
Avoiding High-Methionine Foods: High-methionine foods, including meat and fish, can increase homocysteine levels. Reducing the intake of these foods can be beneficial.
Increasing Physical Activity: Regular physical activity can help lower homocysteine levels and improve overall cardiovascular health. Incorporating exercise into daily routines is highly recommended.
Managing Stress: Stress can worsen the symptoms of CBS gene mutations. Adopting stress management techniques, such as meditation, yoga, and deep breathing exercises, can help mitigate these effects.
Understanding Nitric Oxide’s Role: Nitric oxide acts as a signaling molecule produced by inducible nitric oxide synthase (iNOS) during inflammatory responses. It has potential inhibitory effects on cystathionine β-synthetase (CBS) expression and interacts with other pathways, including its involvement as a vasodilator in cardiovascular functions.
By making these lifestyle adjustments, individuals with CBS gene mutations can better manage their condition and improve their overall quality of life.
Cell Line and Research Implications
CBS Gene Expression in Cell Lines
Research into CBS gene expression has provided valuable insights into its role in both cancerous and normal cells. Studies have shown that CBS overexpression is common in various cancer cell lines, including those from ovarian, breast, and lung cancers. This overexpression is often linked to enhanced cancer cell growth and survival, making CBS a potential target for cancer therapy.
In contrast, CBS expression is typically lower in normal cell lines, such as fibroblast and epithelial cells. This difference suggests that CBS overexpression may be a hallmark of cancer, contributing to the metabolic reprogramming that supports cancer cell proliferation.
Inhibiting CBS in cancer cell lines has been shown to suppress cell growth and induce apoptosis, highlighting the potential of CBS inhibitors as therapeutic agents. Further research is needed to fully understand the role of CBS in cancer and to develop effective CBS inhibitors for clinical use. By studying CBS gene expression in both cancerous and normal cell lines, scientists can better understand the mechanisms underlying CBS-related diseases and develop targeted treatments to improve patient outcomes.
